BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 21816137)

  • 1. Utility of imaging for nutritional intervention studies in Alzheimer's disease.
    de Wilde MC; Kamphuis PJ; Sijben JW; Scheltens P
    Eur J Pharmacol; 2011 Sep; 668 Suppl 1():S59-69. PubMed ID: 21816137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current topics about mild cognitive impairment (MCI)].
    Yamamoto Y
    Seishin Shinkeigaku Zasshi; 2011; 113(6):584-92. PubMed ID: 21815470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging Initiative.
    Ellis KA; Rowe CC; Villemagne VL; Martins RN; Masters CL; Salvado O; Szoeke C; Ames D;
    Alzheimers Dement; 2010 May; 6(3):291-6. PubMed ID: 20451879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging is superior to cognitive testing for early diagnosis of Alzheimer's disease.
    Zamrini E; De Santi S; Tolar M
    Neurobiol Aging; 2004; 25(5):685-91. PubMed ID: 15172748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers in preclinical Alzheimer's disease.
    Chong MS; Lim WS; Sahadevan S
    Curr Opin Investig Drugs; 2006 Jul; 7(7):600-7. PubMed ID: 16869111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers in the diagnosis and management of Alzheimer's disease.
    Wurtman R
    Metabolism; 2015 Mar; 64(3 Suppl 1):S47-50. PubMed ID: 25468144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.
    Mosconi L; De Santi S; Rusinek H; Convit A; de Leon MJ
    Expert Rev Neurother; 2004 Sep; 4(5):831-49. PubMed ID: 15853510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimaging in dementias.
    de Souza LC; Lehéricy S; Dubois B; Stella F; Sarazin M
    Curr Opin Psychiatry; 2012 Nov; 25(6):473-9. PubMed ID: 23037962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination.
    van Wijk N; Broersen LM; de Wilde MC; Hageman RJ; Groenendijk M; Sijben JW; Kamphuis PJ
    J Alzheimers Dis; 2014; 38(3):459-79. PubMed ID: 23985420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDG-PET imaging, EEG and sleep phenotypes as translational biomarkers for research in Alzheimer's disease.
    Platt B; Welch A; Riedel G
    Biochem Soc Trans; 2011 Aug; 39(4):874-80. PubMed ID: 21787316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid imaging in early detection of Alzheimer's disease.
    Nordberg A
    Neurodegener Dis; 2010; 7(1-3):136-8. PubMed ID: 20197692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroimaging in Alzheimer's disease: an overview].
    Masdeu J
    Rev Neurol; 2004 Jun 16-30; 38(12):1156-65. PubMed ID: 15229831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutritional approaches in the risk reduction and management of Alzheimer's disease.
    Mi W; van Wijk N; Cansev M; Sijben JW; Kamphuis PJ
    Nutrition; 2013 Sep; 29(9):1080-9. PubMed ID: 23756280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease.
    Schmand B; Huizenga HM; van Gool WA
    Psychol Med; 2010 Jan; 40(1):135-45. PubMed ID: 19863841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.
    Masters CL; Cappai R; Barnham KJ; Villemagne VL
    J Neurochem; 2006 Jun; 97(6):1700-25. PubMed ID: 16805778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of neuroimaging in mild cognitive impairment.
    Matsuda H
    Neuropathology; 2007 Dec; 27(6):570-7. PubMed ID: 18021379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers for Alzheimer's disease.
    Sonnen JA; Keene CD; Montine KS; Li G; Peskind ER; Zhang J; Montine TJ
    Expert Rev Neurother; 2007 Aug; 7(8):1021-8. PubMed ID: 17678497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial.
    Scheltens P; Kamphuis PJ; Verhey FR; Olde Rikkert MG; Wurtman RJ; Wilkinson D; Twisk JW; Kurz A
    Alzheimers Dement; 2010 Jan; 6(1):1-10.e1. PubMed ID: 20129316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concept of functional imaging of memory decline in Alzheimer's disease.
    Drzezga A
    Methods; 2008 Apr; 44(4):304-14. PubMed ID: 18374274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.